Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital

Inclusion criteria

• Subjects eligible for study participation will satisfy the following criteria:

• Birth weight between 1000g -1800g
• Less than or equal to 34 weeks and 0 days gestational age at birth
• Appropriate for gestational age (AGA)
• Singleton or twin births
• Infant is 21 days of age or less

Exclusion criteria

• Infants with the following conditions prior to and/or at the time of study product initiation are not eligible for entry into the study:

• Expected to be transferred to another facility within 14 days
• Serious congenital abnormalities that may affect growth and development
• Intubated for ventilation at the time of study product initiation
• Grade III or IV periventricular/intraventricular hemorrhage (PVH/IVH)
• Maternal incapacity, maternal drug or alcohol abuse during pregnancy or current abuse, or maternal treatment consistent with human immunodeficiency virus therapy
• Infant has a history of major surgery
• Asphyxia defined as progressive hypoxemia and hypercapnia with significant metabolic acidemia
• Confirmed necrotizing enterocolitis or confirmed sepsis
• Current use or planned use of probiotics
• Participation in another study that has not been approved